Period of time： 2013年1期
Publisher： Future Medicine
Founded in： 2006
Total resources： 64
ISSN： 1746-0794
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Virology,volume 4,issue 1
Menu
Off-label indication: acyclovir as an anti-HIV drug?
By Vanpouille Christophe,Lisco Andrea,Margolis Leonid in (2009)
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.
Access to resources
Recommend
A covalent HIV vaccine: is there hope for the future?
By Paul Sudhir,Planque Stephanie A,Nishiyama Yasuhiro,Hanson Carl V in (2009)
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.Genital co-infections turn Langerhans cells from friends into foes during HIV-1 transmission
By de Jong Marein AWP,Geijtenbeek Teunis BH in (2009)
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.Manipulating miRNA responsiveness to decrease viral pathogenicity
By Russell Stephen J in (2009)
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.6th Australasian Viral Hepatitis Conference
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.HAART in treatment-experienced patients in the 21st century: the audacity of hope
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.Tumor-specific mutations in the Merkel cell polyomavirus integrated genome
By Segondy Michel,Foulongne Vincent in (2009)
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.Advancing full length genome sequencing for human RNA viral pathogens
By Djikeng Appolinaire,Spiro David in (2009)
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.New insights into HBV replication: new opportunities for improved therapies
Future Virology,volume 4,issue 1 , Vol. 4, Iss. 1, 2009-01 , pp.
Previous
Next